Atlas Trials

Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract Cancer

Clinical trial NCT04072445 · COMPLETED

Trial details

NCT number
NCT04072445
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Bile Duct CarcinomaAdvanced Gallbladder CarcinomaRefractory Bile Duct CarcinomaRefractory Gallbladder CarcinomaStage III Distal Bile Duct Cancer AJCC v8Stage III Gallbladder Cancer AJCC v8Stage III Intrahepatic Bile Duct Cancer AJCC v8Stage IIIA Distal Bile Duct Cancer AJCC v8Stage IIIA Gallbladder Cancer AJCC v8Stage IIIA Intrahepatic Bile Duct Cancer AJCC v8Stage IIIB Distal Bile Duct Cancer AJCC v8Stage IIIB Gallbladder Cancer AJCC v8
Start date
2019-10-18
Primary completion
2021-08-13
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.